Skip to content
Search

Latest Stories

Submit Guest Post

Small businesses to benefit as Walmart plans to triple exports from India by 2027

WALMART on Thursday(10) said it will triple its exports of goods from India to $10 billion each year by 2027.

The expansion in sourcing will include helping develop new suppliers in categories such as food, pharmaceuticals, consumables, health and wellness, and general merchandise, along with apparel, homeware and other key Indian export categories, the company said in a statement.


The global retailer said its new commitment to export '$10bn of India-made goods each year by 2027' is expected to provide a significant boost to micro, small and medium-sized enterprises (MSMEs) in India, alongside ongoing efforts such as the Flipkart Samarth and Walmart Vriddhi supplier development programmes.

Announcing the commitment, Walmart president and CEO Doug McMillon said as an international retailer that brings value to customers and communities worldwide, Walmart understands that local entrepreneurs and manufacturers are vital to the success of the global retail sector.

"And we see huge potential for Indian suppliers to grow their businesses by leveraging the unique scale and global distribution opportunity Walmart provides," he added.

McMillon further said: "By significantly accelerating our annual India exports in the coming years, we are supporting the Make in India initiative and helping more local businesses reach international customers while creating jobs and prosperity at home in India."

It is also a way for Walmart to bring more high-quality, India-made goods to millions of customers all across the world, he added.

In order to accelerate exports from India, Walmart said it will strengthen the development of the supply chain ecosystem in the country, both by boosting existing exporters and by expanding the nation's pool of export-ready businesses.

Stating that it has sourced goods from India for more than 20 years, Walmart said it brings global market intelligence and demand forecasts that help suppliers with strategic planning.

"This support has contributed to the global success of hundreds of companies, including Welspun, LT Foods and Aniket Metals, plus fast-growing export businesses like Global Green Company, and many more," the company added.

Walmart said India is already one of its top sourcing markets with annual exports worth about $3bn.

The company said India-made apparel, homeware, jewellery, hardlines and other popular products currently reach customers in 14 markets, including the US, Canada, Mexico, Central America, and the UK, via its Global Sourcing office in Bengaluru, which opened in 2002

"As the sourcing hub ramps up over the next few years, the local team will be empowered to make an even greater impact for even more local businesses in a wider range of sectors," it said.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Hair Loss risks

Popular GLP-1 weight loss drugs are facing fresh scrutiny over reports of hair loss.

iStock

Hair loss risk up by 68 per cent? New study puts GLP-1 drugs under the spotlight

  • Researchers found GLP-1 drugs were associated with up to a 68 per cent higher risk of hair loss than some other diabetes medicines.
  • UK regulators have received more than 1,200 reports of hair loss linked to semaglutide and tirzepatide since last year.
  • Experts say rapid weight loss may be the most likely explanation, but further research is needed.

Popular GLP-1 weight loss drugs such as Mounjaro, Ozempic and Wegovy are under fresh scrutiny after a major study found they may be linked to a higher risk of hair loss. The findings add to a growing number of reports already being reviewed by health regulators in both the UK and the US, although researchers say more evidence is needed before any direct link can be confirmed.

The study, published in the British Medical Journal (BMJ), analysed health records from around 50,000 adults and compared people taking GLP-1 receptor agonists with those using other medicines to manage type 2 diabetes. Researchers found that people using GLP-1 drugs had a 37 per cent higher risk of developing alopecia than those taking SGLT-2 inhibitors, while the risk was 68 per cent higher compared with people using DPP-4 inhibitors.

Keep ReadingShow less